Prof Stricker went on to say that the MRI ultrasound-fusion guided biopsy minimised the risk of infection, improved the accuracy of sampling and minimised the number of biopsy cores required to establish a diagnosis of prostate cancer. Prof Stricker has now been trialling the technique for six months and now offers it as a standard of care to all his patients.